Ketamine Treatment and Global Brain Connectivity in Major Depression
Ketamine Treatment and Global Brain Connectivity in Major Depression
复制标题
DOI:
10.1038/npp.2016.186
复制
发表时间:
2017-05-01
影响因子:
7.6
通讯作者:
Murrough, James W.
中科院分区:
文献类型:
--
作者:
Abdallah, Chadi G.;Averill, Lynnette A.;Murrough, James W.
Capitalizing on recent advances in resting-state functional connectivity magnetic resonance imaging (rs-fcMRI) and the distinctive paradigm of rapid mood normalization following ketamine treatment, the current study investigated intrinsic brain networks in major depressive disorder (MDD) during a depressive episode and following treatment with ketamine. Medication-free patients with MDD and healthy control subjects (HC) completed baseline rs-fcMRI. MDD patients received a single infusion of ketamine and underwent repeated rs-fcMRI at 24 h posttreatment. Global brain connectivity with global signal regression (GBCr) values were computed as the average of correlations of each voxel with all other gray matter voxels in the brain. MDD group showed reduced GBCr in the prefrontal cortex (PFC) but increased GBCr in the posterior cingulate, precuneus, lingual gyrus, and cerebellum. Ketamine significantly increased GBCr in the PFC and reduced GBCr in the cerebellum. At baseline, 2174 voxels of altered GBCr were identified, but only 310 voxels significantly differed relative to controls following treatment (corrected alpha